Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples

Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples

<p>Abstract</p> <p>Background</p> <p>Genomic tests are available to predict breast cancer recurrence and to guide clinical decision making. These predictors provide recurrence risk scores along with a measure of uncertainty, usually a confidence interval. The confidence...

Full description

Bibliographic Details
Main Authors: Gulley Margaret L, Parker Joel S, Li Yan, Hu Zhiyuan, Elloumi Fathi, Amos Keith D, Troester Melissa A
Format: Article
Language:English
Published: BMC 2011-06-01
Series:BMC Medical Genomics
Subjects:
biomarker validation
genomic assays
breast cancer
normal tissue
bias
Online Access:http://www.biomedcentral.com/1755-8794/4/54

Internet

http://www.biomedcentral.com/1755-8794/4/54

Similar Items